These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1708925)

  • 21. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
    Valdevenito R; Melman A
    Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection.
    Dinsmore WW
    Ulster Med J; 1990 Oct; 59(2):174-6. PubMed ID: 2278115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.
    Montorsi F; Guazzoni G; Bergamaschi F; Zucconi M; Rigatti P; Pizzini G; Miani A; Pozza G
    Acta Diabetol; 1994 Apr; 31(1):1-5. PubMed ID: 8043890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence.
    Montorsi F; Guazzoni G; Bergamaschi F; Dodesini A; Rigatti P; Pizzini G; Miani A
    Urology; 1993 Nov; 42(5):554-8. PubMed ID: 7694416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intracavernous pharmacotherapy for organic impotence in the elderly].
    Richter S; Shalev M; Nissenkorn I
    Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction.
    Ghanem H; Sherif T; Adbel-Gawad T; Asaad T
    Int J Impot Res; 1998 Dec; 10(4):211-4. PubMed ID: 9884916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Corpus cavernosum injection treatment of erectile impotence].
    Lenk S; Schönherr G; Korner I
    Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intracavernous pharmacotherapy.
    Sidi AA
    Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracorporal injection of papaverine and phentolamine in the management of impotence.
    Robinette MA; Moffat MJ
    Br J Urol; 1986 Dec; 58(6):692-5. PubMed ID: 3801830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracavernosal injection therapy with and without sexological counselling in men with erectile dysfunction.
    van der Windt F; Dohle GR; van der Tak J; Slob AK
    BJU Int; 2002 Jun; 89(9):901-4. PubMed ID: 12010236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction.
    Montorsi F; Guazzoni G; Bergamaschi F; Ferini-Strambi L; Barbieri L; Rigatti P
    J Urol; 1993 May; 149(5 Pt 2):1291-5. PubMed ID: 7683061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracavernous vasoactive pharmacotherapy: the impact of a new self-injection device.
    Montorsi F; Guazzoni G; Bergamaschi F; Orlandini A; Da Pozzo L; Barbieri L; Rigatti P
    J Urol; 1993 Dec; 150(6):1829-32. PubMed ID: 7693979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Percutaneous use of vasoactive drugs in the diagnosis and treatment of erectile impotence].
    Pastorini S; Marino G; Cocimano V; Marten Perolino R
    Minerva Urol Nefrol; 1992; 44(3):191-3. PubMed ID: 1492270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B; Donatucci CF; Kaula N; Lue TF
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Injections of papaverine and regitine into the corpora cavernosa for erectile dysfunction: clinical results in 60 patients.
    Nelson RP
    South Med J; 1989 Jan; 82(1):26-8. PubMed ID: 2463675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
    Stief CG; Bähren W; Beckert R; Altwein JE
    J Urol (Paris); 1986; 92(6):349-51. PubMed ID: 3794379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracavernosal injection therapy for impotence: preliminary results.
    Gilling PJ; Wright WL; Gray JM
    N Z Med J; 1988 Jun; 101(848):423-4. PubMed ID: 3393333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.